Ottawa Heart Institute Research Corporation

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Utility of a Smart Phone Application in Assessing Radial Artery Patency - the CAPITAL iRADIAL Study

Not Applicable

Completed

Conditions: Coronary Heart Disease

Interventions: Other: Iphone artery assessment
Other: Modified Allen Test

First Posted Date: 2015-08-11

Last Posted Date: 2023-02-08

Lead Sponsor: Ottawa Heart Institute Research Corporation

Target Recruit Count: 438

Registration Number: NCT02519491

Locations: 🇨🇦
University of Ottawa Heart Institute, Ottawa, Ontario, Canada

HYbrid CoronAry Revascularization in DiabeticS

Not Applicable

Completed

Conditions: Heart Disease
Diabetes

Interventions: Procedure: Treatment
Procedure: Control

First Posted Date: 2015-07-22

Last Posted Date: 2020-01-22

Lead Sponsor: Ottawa Heart Institute Research Corporation

Target Recruit Count: 20

Registration Number: NCT02504762

Locations: 🇨🇦
Division of Cardiac Surgery, University of Ottawa Heart Institute, Ottawa, Ontario, Canada

Left Internal Thoracic Artery Bypass Versus Percutaneous Revascularization in Diabetics

Not Applicable

Withdrawn

Conditions: Diabetes Mellitus
Coronary Artery Disease

Interventions: Procedure: Percutenous Coronary Intervention
Procedure: Minimally Invasive Coronary Bypass

First Posted Date: 2015-02-04

Last Posted Date: 2018-05-03

Lead Sponsor: Ottawa Heart Institute Research Corporation

Registration Number: NCT02355288

Biomarkers to Classify Heart Failure

Active, not recruiting

Conditions: Heart Failure

First Posted Date: 2015-01-27

Last Posted Date: 2024-02-02

Lead Sponsor: Ottawa Heart Institute Research Corporation

Target Recruit Count: 511

Registration Number: NCT02347722

Locations: 🇨🇦
University of Ottawa Heart Institute, Ottawa, Ontario, Canada

Use of Glidesheath Slender to Reduce Radial Artery Occlusion and Vascular Access Site Complications Following Transradial Coronary Angiography

Not Applicable

Completed

Conditions: Embolism and Thrombosis of the Radial Artery
Coronary Heart Disease

Interventions: Device: Glidesheath Slender
Device: standard 6- French radial sheath

First Posted Date: 2014-12-24

Last Posted Date: 2022-01-28

Lead Sponsor: Ottawa Heart Institute Research Corporation

Target Recruit Count: 400

Registration Number: NCT02324764

Locations: 🇨🇦
University of Ottawa Heart Institute, Ottawa, Ontario, Canada

Cadmium-zinc-telluride (CZT) Imaging of Myocardial Blood Flow (MBF) (SPECT MBF)

Not Applicable

Conditions: Coronary Heart Disease

Interventions: Other: single photon emission computed tomography

First Posted Date: 2014-11-02

Last Posted Date: 2021-04-01

Lead Sponsor: Ottawa Heart Institute Research Corporation

Target Recruit Count: 90

Registration Number: NCT02280941

Locations: 🇨🇦
University of Ottawa Heart Institute, Ottawa, Ontario, Canada

A Pilot Study Evaluating Heart and Lung Metabolism in Pulmonary Hypertension Associated With Left Heart Disease

Not Applicable

Terminated

Conditions: Pulmonary Hypertension

Interventions: Radiation: FDG PET scan

First Posted Date: 2014-09-11

Last Posted Date: 2018-08-31

Lead Sponsor: Ottawa Heart Institute Research Corporation

Target Recruit Count: 2

Registration Number: NCT02237378

Locations: 🇨🇦
University of OttawaHeart Institute, Ottawa, Ontario, Canada

The Effects of Statin Therapy on Coronary Flow Reserve and Inflammatory Markers in HIV-Positive Patients

Phase 4

Completed

Conditions: Cardiovascular Disease (CVD)
Human Immunodeficiency Virus (HIV)

Interventions: Drug: Rosuvastatin

First Posted Date: 2014-09-09

Last Posted Date: 2018-10-05

Lead Sponsor: Ottawa Heart Institute Research Corporation

Target Recruit Count: 35

Registration Number: NCT02234492

Locations: 🇨🇦
University of Ottawa Heart Institute, Ottawa, Ontario, Canada
🇨🇦
The Ottawa Hospital-General Campus, Ottawa, Ontario, Canada

Correlation of the Arrhythmia Mechanism and Substrate to Ablate Persistent Atrial Fibrillation Study

Not Applicable

Active, not recruiting

Conditions: Persistent Atrial Fibrillation

First Posted Date: 2014-07-08

Last Posted Date: 2024-10-16

Lead Sponsor: Ottawa Heart Institute Research Corporation

Target Recruit Count: 52

Registration Number: NCT02184013

Locations: 🇨🇦
University of Ottawa Heart Institute, Ottawa, Ontario, Canada

Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial

Phase 4

Active, not recruiting

Conditions: Atrial Fibrillation
Stroke

Interventions: Drug: Rivaroxaban
Drug: Acetylsalicylic acid

First Posted Date: 2014-06-20

Last Posted Date: 2024-07-17

Lead Sponsor: Ottawa Heart Institute Research Corporation

Target Recruit Count: 1284

Registration Number: NCT02168829

Locations: 🇩🇪
Segeberger Liniken, Bad Segeberg, Schleswig-Holstein, Germany
🇩🇪
UKSH Lubeck, Lubeck, Schleswig-Holstein, Germany
🇦🇺
Heart Rhythm Clinic, Nedlands, Western Australia, Australia

and more 52 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy